首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 390 毫秒
1.
Kimura病与ALHF的对比观察——附6例报告并文献复习   总被引:4,自引:0,他引:4  
与国外早期文献不同,近年来国外诸多文献指出:Kimura病与血管淋巴组织增生伴嗜酸性细胞增多(ALEH)实际为两种疾病,而不是同一种疾病。本文报道了3例典型Kimura病与3例ALEH病,结合支持两者为两种不同病变的观点。  相似文献   

2.
CRKL是由22号染色体q11的crkl基因编码的含SH2、SH3结构域的39kDa的连接蛋白。CRKL羧基端SH3结构域与C3G、SOS、P13-K、HPKl、c-ABL或BCR/ABL结合,CRKL氨基端SH2结构域与酷氨酸磷酸化的蛋白如CBL、HEF1、CAS、STAT5或paxillin结合,在正常造血细胞和白血病中BCR/ABL的主要底物,与BCR/ABL和c-ABL形成连接复活复合物。  相似文献   

3.
探讨用3-磷酸甘油脱氢酶偶联法测定血清中醛缩酶(ALD)活性的最佳反应条件。反应体系的终末浓度:TEA100mmol/L,FDP4mmol/L,碘乙酸0.22mmol/L,NADH0.26mmol/L,GDH≥1000U/L,TPI≥1500U/L,LD≥1000U/L。最适pH在7.8~8.0,Km为7.2×10-3mmol/L。批内CV:酶活性在7.34U/L和65.06U/L时,CV分别为5.7%和1.4%;批间CV:酶活性在11.89U/L和100.08U/L时,CV分别为6.0%和3.3%,酶活性线性范围至少可达180U/L。健康人60名,ALD活性为4.53±1.17(x±s)U/L,男女两组均值无显著性差异。本文对TEA-HCl(pH8.0)、Tris-HCl(pH8.0)和Colidine-HCl(pH7.5)三种缓冲液用于ALD活性测定效果进行了评价,结果表明在TEA缓冲液中所测ALD活性最高;TEA和Colidine两种缓冲液的浓度在25~150mmol/L范围内对ALD活性无影响,Tris缓冲液在50mmol/L时测得酶活性较高,缓冲液浓度过高或过低,酶活性均有所下降  相似文献   

4.
系统性红斑狼疮抗ENA抗体及抗核抗体的检测   总被引:3,自引:0,他引:3  
系统性红斑狼疮(SLE)是一种慢性多系统的疾病。伴有多种血清自身抗体的出现,我们采用免疫印迹法技术,对30例SLE病人和20例正常人进行了抗ENA抗体和ANA的测定,测定结果,抗sm10例为33.3%,抗uiRNP抗体8例为26.6%两者混合型11例为36.6%,1例阴性。20例正常人为阴性。  相似文献   

5.
目的:探讨血清酮体比值(AKBR)对判断感染性多脏器功能失常综合征病情轻重程度和预后的意义。方法:测定正常对照组、肝硬化组、急性感染组(又分A、B、C3组)患者乙酰乙酸(AcAc)、β羟丁酸(3HB)及AKBR等指标水平。结果:肝硬化组AcAc〔(0.42±0.15)mmol/L〕和3HB〔(0.82±0.18)mmol/L〕明显低于正常对照组〔(0.99±0.20)mmol/L和(1.40±0.25)mmol/L〕,P均<0.01;急性感染A、B、C3组的PaO2、乳酸、阴离子间隙具有显著性差异(P均<0.01);AKBR与APACHEⅢ评分呈明显负相关(r=-0.812,P<0.001);血清酮体水平与APACHEⅢ评分间无明显直线相关关系(r=0.163,P>0.05);AKBR和PaO2与APACHEⅢ评分间有明显相关性(r=0.722,P<0.01)。结论:AKBR能更早期、直接、准确地反映肝细胞线粒体的受损程度和能量代谢状态,可以作为评估感染性MODS病情严重程度及预后的重要指标。  相似文献   

6.
1 概 况11 定义 同源病是指同一致病因素使不同脏器或系统同时或相继受到损害。虽同源,但受损脏器各异,故其临床表现多样。12 概念 SLE是一种病因不明的自身免疫缺陷性疾病,全身各脏器系统可同时或相继受累,肺动脉亦可受累,发生一系列病理生理变化,导致肺动脉高压(pulmonaryarterialhypertension,PAH)。PAH是SLE的临床表现,其他如心包炎、心内膜炎、皮肤病变、胸膜炎等属同源同因,又各有其临床特征,故PAH的发生与SLE属同源病。121 发病率 近年文献报道的SLE致PAH发病率有增高…  相似文献   

7.
本实验以双抗体夹心ELIsA检测方法,发现SLE病人血清sIL-2P水平显著高于正常人,疾病活动期高于非活动期,且与SLE疾病活动分数和血沉成正相关,而与C3、C4和CH50成负相关,但与抗ds-DNA抗体和ANA无相关性。提示血清sIL-2R是监测SLE疾病活动性的敏感定量指标。  相似文献   

8.
刘亚光  尹培达 《新医学》1996,27(1):16-17
本实验以双抗体夹心ELISA检测方法,发现SLE病人血清SIL-2R水平显著高于正常人,疾病活动期高于非活动期,且与SLE疾病活动分数和血沉成正相关,而与C3,C4和CH50成负相关,但与抗ds-DNA抗体和ANA无相关性,提示血清sIL-2R是监测SLE疾病活动性的敏感定量指标。  相似文献   

9.
目的探讨重组抗原在戊型肝炎病毒(HEV)感染诊断中的应用。方法用HEV重组抗原建立酶免疫试验(EIA)检测肝病患者和健康人群血清中抗戊型肝炎病毒抗体(抗-HEV)。结果55份用新加坡DBL公司抗-HEV诊断试剂盒检测为抗-HEV阳性的肝炎患者血清中,53份(96.4%)用本方法检测也为阳性;45份DBL试剂盒检测为抗-HEV阴性的血清中,本法检测有3份为抗-HEV阳性。检测甲、乙、丙型肝炎患者血清各30份,抗-HEV阳性率分别为13.3%(4/30)、13.3%(4/30)和10.0%(3/30)。健康人抗-HEV阳性率为5.0%(8/160)。重组抗原与合成肽抗原混合用于EIA,可以检出两种抗原单独阳性的抗-HEV。结论以重组抗原为基础的EIA特异性强、灵敏度高、快速简便,是戊型肝炎血清学诊断及流行病学调查的一种可靠方法  相似文献   

10.
APACHEⅡ对高龄外科危重患者的预后评估   总被引:1,自引:0,他引:1  
为了准确评估高龄外科危重患者的预后及治疗效果,作者对206例高龄危重患者进行了分析,采用APACHEⅡ评分系统对疾病的危重程度进行评分,并对前后两个阶段病例进行分组对照,结果显示:APACHEⅡ评分均值为20.3分,死亡患者(20例)的APACHEⅡ评分(26.3分)明显高于存活患者(186例)的APACHEⅡ评分(15.4分),差异有显著性。随着APACHEⅡ评分增高,死亡率亦逐渐增高。通过APACHEⅡ评分的动态观察,显示了对高龄危重患者治疗水平的变化,第一组患者经过两天治疗APACHEⅡ评分下降2.7分,第二组下降6.6分,两组病种及最初进入ICU病房的APACHEⅡ评分无差异,在ICU病房两组出现了不同的死亡率:12.6%与6.8%,有显著性差异(p<0.05)。作者认为:在高龄外科危重患者的临床工作中,APACHEⅡ评分系统作为评估其预后指标有着重要作用。  相似文献   

11.
Kimura’s disease (KD) is a rare chronic inflammatory or allergic disease. Angiolymphoid hyperplasia with eosinophilia (ALHE) is a benign vascular neoplasm. Their relationship has always been debated. This article reports two rare cases, one of each disease. One patient was a 48-year-old female that presented with a mass on her right mandible. She also had oedema erythema and wheals on her lower limbs. She was diagnosed with Kimura’s disease complicated with chronic urticaria. The second patient was a 23-year-old female that presented with multiple nodules of unequal size on the scalp. She was diagnosed with angiolymphoid hyperplasia with eosinophilia. The first patient recovered after being treated with surgical resection, glucocorticosteroids, cyclophosphamide and radiotherapy. The second patient underwent the first stage of surgical excision and is currently being followed-up. Comparison of the clinical and histopathological features of these two cases supports the theory that KD and ALHE are two separate disease entities.  相似文献   

12.
目的:探讨血管淋巴样增生伴嗜酸粒细胞增多症(ALHE)的临床表现、病理特点及诊治情况,提高对本病诊断和治疗的认识。方法:分析华山医院1999年1月-2004年12月13例确诊为ALHE患者的临床和病理资料、随访及其转归。结果:本病临床上表现为单发或多发红色至褐色的丘疹或结节,无淋巴结受累,通常局限在头面部和颈部。本病容易被误诊,但特征性的病理改变(包括血管增生、内皮细胞突入管腔以及混合性淋巴细胞、嗜酸粒细胞浸润)有助于确诊。手术切除对单发损害疗效好,而多发损害则治疗困难且客易复发。结论:组织病理学检查对于诊断ALHE是必需的。手术切除的疗效最好,但可以复发。  相似文献   

13.
目的 了解成都地区性病患者淋球菌、沙眼衣原体和解脲支原体感染现状及其变化情况。方法 用聚合酶链反应杂交梳方法对820例性病患者标本进行三种病原体的检测,并进行统计分析。结果 淋球菌检出率为21.3%,居首位,三种病原体感染情况均以男性高于女性,这与两年前调查结果略有不同,当时淋球菌感染率为女性高于男性。两次调查均以年轻者感染率较高。结论 所查三种病原菌是该地区引起性病的主要致病菌,其感染有年轻化真  相似文献   

14.
Group A streptococcal pharyngitis of is a common infectious disease with a well-recognized clinical pattern, as opposed to that attributed to group C assault. The aim of this study was to identify the clinical features of group C streptococcal pharyngitis in children. In total, 144 children participated in the study, consisting of three distinct categories. Group I patients consisted of children with group A streptococcal pharyngitis, group II patients included children with group C streptococcal pharyngitis,, while children with pharyngitis with no isolated causative agent constituted group III patients. With the exception of sore throat, which was three times more common in group I patients compared to group II patients, there were no other differences in symptoms and signs between these two groups. Similarly, no difference was found between group II patients and group III patients with respect to clinical features. Two or more Centor criteria were found in 77% of the children with group C streptococcal pharyngitis and in 89% of the children with group A streptococcal pharyngitis. It is concluded that the clinical features of group C streptococcal pharyngitis are similar to but milder than those of group A streptococcal pharyngitis.  相似文献   

15.
BACKGROUND AND STUDY AIMS: There are sporadic reports concerning foreign material as a cause of choledocholithiasis. Gallstones obtained endoscopically from the biliary duct were analyzed to determine their structure and the presence of foreign material. The possible correlation between foreign material in gallstones and clinical data was investigated. PATIENTS AND METHODS: Gallstones were examined qualitatively using a crystallographic analysis by X-ray powder diffraction, and the foreign material which was found was subjected to morphological analysis using polarization microscopy. Patients' clinical data were obtained from clinical records, physical examination and documentation. RESULTS: Out of a group of 54 patients, foreign material was found in CBD stones of six individuals (11.1%). Four of these patients were from the group who had undergone a previous cholecystectomy (29/54, 13.8%), and surgical suturing material was found in these four. On the other hand, in the group who had not undergone the operation, foreign material was found in two patients out of 25 (8%); in one case it was cellulose and in the other case the fibre was not identified. CONCLUSIONS: Foreign material can account for lithiasis in the biliary duct. In contrast to present reports in the literature, we have proved that this is possible even in patients without previous surgical intervention in the pancreatobiliary region.  相似文献   

16.
17.
As there have been reports of differences in mean levels of serum immunoglobulins between patients with ulcerative colitis and Crohn's disease, serum IgG, IgA, and IgM were estimated in 158 patients with inflammatory bowel disease and the results correlated with the clinical features of the patients. Although a higher mean IgG level in ulcerative colitis compared to Crohn's disease was confirmed, no difference was found when the comparison was limited to patients with colonic Crohn's disease. Patients with either disease had higher mean IgM levels than controls, and the IgM levels were higher on treatment with corticosteroids and showed a tendency to rise in remission. IgG and IgM levels were also higher in both diseases if extraintestinal manifestations were present. It is concluded that if clinical features, particularly disease site, are taken into account, the overall immunoglobulin responses in these two diseases show no differences.  相似文献   

18.
Angio-immunoblastic lymphadenopathy (AIL) is a disease of unknownaetiology and pathogenesis. It has features of hyperimmunity,immune deficiency and can behave like a malignant lymphoma.An underlying abnormality of T-cell regulatory function hasbeen proposed. We report ten patients with AIL followed prospectivelyand review 200 cases from the literature. As well as showingthe typical features described in previous retrospective seriesnamely: constitutional symptoms, generalized lymphadenopathy,hepatosplenomegaly, skin eruptions, hypergammaglobulinaemiaand characteristic lymph node histology; four patients had oedemawith ascites or pleural effusions associated with hyponatraemiaand hypoalbuminaemia. We have also observed low free thyroxineindices in three patients with elevated TSH levels in two, butwithout clinical features of hypothyroidism. Seven of the patientsin this study were treated with prednisone and cyclophosphamide.Three achieved complete remission but only one patient has survivedlonger than two years. Failure to achieve complete remissionhas been associated with a 90 per cent mortality within oneyear of the onset of disease in the reports reviewed. Corticosteroidsalone have produced only a 40 per cent rate of remission. Themanagement of poor responders, non-responders and many relapsecases is unsatisfactory. More instensive chemotherapy is veryhazardous, increasing the already high risk of severe infections,and is often unsuccessful. Histological features recently reportedto represent co-existent immunoblastic lymphoma at diagnosiswere recognized in three of our patients, two of which wenton to develop definite lymphoma.  相似文献   

19.
Angio-immunoblastic lymphadenopathy (AIL) is a disease of unknown aetiology and pathogenesis. It has features of hyperimmunity, immune deficiency and can behave like a malignant lymphoma. An underlying abnormality of T-cell regulatory function has been proposed. We report ten patients with AIL followed prospectively and review 200 cases from the literature. As well as showing the typical features described in previous retrospective series namely: constitutional symptoms, generalized lymphadenopathy, hepatosplenomegaly, skin eruptions, hypergammaglobulinaemia and characteristic lymph node histology; four patients had oedema with ascites or pleural effusions associated with hyponatraemia and hypoalbuminaemia. We have also observed low free thyroxine indices in three patients with elevated TSH levels in two, but without clinical features of hypothyroidism. Seven of the patients in this study were treated with prednisone and cyclophosphamide. Three achieved complete remission but only one patient has survived longer than two years. Failure to achieve complete remission has been associated with a 90 per cent mortality within one year of the onset of disease in the reports reviewed. Corticosteroids alone have produced only a 40 per cent rate of remission. The management of poor responders, non-responders and many relapse cases in unsatisfactory. More instensive chemotherapy is very hazardous, increasing the already high risk of severe infections, and is often unsuccessful. Histological features recently reported to represent co-existent immunoblastic lymphoma at diagnosis were recognized in three of our patients, two of which went on to develop definite lymphoma.  相似文献   

20.
The trigeminal autonomic cephalalgias (TACs) and hemicrania continua (HC) share many clinical characteristics including unilateral pain and ipsilateral autonomic features. We report a patient with a history of migraine without aura who developed cluster headache and HC simultaneously. The distinctive clinical features and differential response profiles to various treatments indicates that they are distinct disorders. We then review previous reports of patients with coexisting TACs and HC and discuss the relationship between these families of primary headache disorders.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号